A carregar...
Switching on the green light for chimeric antigen receptor T‐cell therapy
Adoptive cellular therapy involving genetic modification of T cells with chimeric antigen receptor (CAR) transgene offers a promising strategy to broaden the efficacy of this approach for the effective treatment of cancer. Although remarkable antitumor responses have been observed following CAR T‐ce...
Na minha lista:
| Publicado no: | Clin Transl Immunology |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6500780/ https://ncbi.nlm.nih.gov/pubmed/31073403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1046 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|